Subchronic effects of eszopiclone (Lunesta) on pain behavior and circuitry in primary insomnia

Trial Profile

Subchronic effects of eszopiclone (Lunesta) on pain behavior and circuitry in primary insomnia

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Insomnia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Oct 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 03 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top